Lyell Immunopharma

Looking forward to being San Diego for #ASH2024 and presenting the first clinical results of IMPT-314, our next-generation CAR T-cell product candidate for the treatment of B-cell #Lymphoma

This December, we stand together to celebrate Human Rights Month—a time to reflect on the universal rights and freedoms that belong to every individual, everywhere. Let's unite in advocating for equality, justice, and dignity for all. Every voice matters, and together, we can build a world where respect for human rights is not just an ideal but a reality. Join us in spreading awareness, amplifying voices, and supporting initiatives that protect human rights around the globe. Because #HumanRightsAreForAll.#HumanRightsMonth #EqualityForAll #StandUpForRights #Justice #TogetherForChange #WeAreHuman https://lnkd.in/gXJPPJq

Today is an exciting day for Lyell and our vision of developing cell therapies that overcome the biggest challenges to achieving better outcomes for patients. #celltherapy #CART https://lyell.com/

We're #hiring a new Vice President, Process Sciences in Seattle, Washington. Apply today or share this post with your network.

Congratulations this talented and dedicated group of scientists Aileen Li, PhD, Jessica B., Jia Lu, Quinn Walker, Rowena Ellsworth, Hajime Hiraragi, Bijan Boldajipour, Purnima Sundar, Shobha Potluri, Gary Lee, Omar Ali, and Alexander Cheung on the publication in Scientific Reports that describes our novel Stim-R T cell activation technology. CAR T cells generated using our Stim-R technology showed improved potency, expansion and cytokine production compared to standard T-cell activation reagent control. In addition, characterization of Stim-R derived CAR T-cells revealed retention of a stem-like cell population and downregulation of exhaustion-associated gene sets.  This innovative technology is incorporated in LYL119, our next generation ROR1 CAR T cell product candidate entering a Phase 1 development in a clinical trial that will initially enroll patients with ROR1‑positive platinum‑resistant ovarian cancer or endometrial cancer. https://lnkd.in/gha5VchW

We are excited to announce we earned Great Place to Work® Certification™ ! While we pause to celebrate this accomplishment, we also recognize the importance of hearing what our team has to say and taking action to be an even better place to work. Listening to our employees, adapting to changing needs, and refining our policies and practices will ensure that Lyell remains a Great Place To Work®. At Lyell, we are all here to do the best work of our lives. Our employees thrive in an environment of trust, empowerment and support. With a team of world class leaders and scientists, we’re breaking down barriers and pioneering novel science to develop cell therapies for patients with cancer. We are Lyellites and we are a Great Place To Work®. WE’RE HIRING! Looking to grow your career at a company that puts its people first? Visit our careers page at https://lnkd.in/gmGmDCpN.

Happy #Pride! Lyell believes in fostering an inclusive and diverse workplace where everyone feels respected, valued and celebrated. Pride Month is an opportunity for us to recognize and honor the LGBTQ+ community, their contributions and the progress we have made towards equality!

We are less than a month out from Biocom California Institute’s inaugural Bay Area Life Science Career Expo, in partnership with NOVAworks. Job seekers will be able to explore opportunities with leading life science companies, including AbbVie, Airgas, Amgen, Arsenal Biosciences, Inc., Cerus, Cytokinetics, Karius, Lyell Immunopharma, Merck, Vector Labs and more. The Expo also offers workshops led by industry experts and the opportunity to get to know the Bay Area’s #lifescience industry. If you’d like to explore a career in the life science industry, join us!     Employers: If you are a Bay Area life science company who is actively hiring and would like to have a table, please register here https://lnkd.in/gAHM-UfR and we’ll contact you for additional information.    View the full program and register here: https://lnkd.in/g-_i8p5R. #lifesciences, #biotech, #biotechnology, #biopharma, #careerfair, #jobfair, #bayarea #jobseeker

We are excited to be presenting three abstracts of new nonclinical data at #AACR2024 https://lnkd.in/gXFbfbdn

During #WomensHistoryMonth, we celebrate the women Lyellites working every day to advance our mission of developing T cell therapies to defeat solid tumors